Lei P Wang, Pablo Shimaoka Chagas, Évila Lopes Salles, Sahar Emami Naeini, Jules Gouron, Hannah M Rogers, Hesam Khodadadi, Bidhan Bhandari, Ahmet Alptekin, Xu Qin, Kumar Vaibhav, Vincenzo Costigliola, David C Hess, Krishnan M Dhandapani, Ali S Arbab, Martin J Rutkowski, Jack C Yu, Babak Baban
Glioblastoma (GBM) is an extremely aggressive primary brain tumor with poor prognosis, short survival time post-diagnosis and high recurrence. Currently, no cure for GBM exists. The identification of an effective therapeutic modality for GBM remains a high priority amongst medical professionals and researches. In recent studies, inhalant cannabidiol (CBD) has demonstrated promise in effectively inhibiting GBM tumor growth. However, exactly how CBD treatment affects the physiology of these tumor cells remains unclear...
May 7, 2024: Medical Oncology